glp 1 for thyroid issues Increased screening may lead to higher cancer risk after GLP-1 initiation No Increased Risk for Thyroid

Both GPR40 and GPR120 are expressed in cholecystokinin (CCK)-producing cells, and CCK secretion is reduced in both GPR40 KO and GPR120 KO mice

According to the World Health Organization (WHO), over 60 million people in Europe live with diabetes, while noncommunicable diseases account for nearly 90% of deaths in the region, driving increased demand for effective treatments such as GLP-1 receptor agonists

Klting, N., Kern, M., Moruzzi, M., Kovacs, P., Chakaroun, R., Schn, M

Current research suggests that tirzepatide, like GLP-1RAs, may enhance numerous cardiovascular risk factors

The care and attention to detail gave me the confidence to begin this journey